Free Trial

BriaCell Therapeutics (BCTX) SEC Filings & 10K Form

BriaCell Therapeutics logo
$0.79
-0.02 (-2.46%)
(As of 11/1/2024 ET)

Recent BriaCell Therapeutics SEC Filings

DateFilerForm TypeView
11/01/2024
3:05 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
9:12 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 424B5
10/01/2024
3:02 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
9:22 AM
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
09/12/2024
3:25 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
7:50 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
7:50 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:10 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:58 AM
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
05/17/2024
3:51 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:10 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 424B5
03/18/2024
4:15 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/31/2024
11:15 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form EFFECT
01/31/2024
4:24 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2024
4:00 PM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/08/2024
10:01 AM
BriaCell Therapeutics (Subject)
BriaCell Therapeutics Corp. (Subject)
Copia Fund LP (0001718996) (Filed by)
Form SCHEDULE 13G
11/30/2023
6:00 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2023
7:45 AM
BriaCell Therapeutics (Filer)
BriaCell Therapeutics Corp. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners